Peer-led Community-based PrEP Delivery Among Youth in Brazil

NCT06661356 — Not applicable, Not yet recruiting, 1400 participants, University of Alabama at Birmingham

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Determining the Impact of Peer-led Community-based PrEP Delivery Among Youth in Brazil: A Randomized Controlled Trial

RegistryNCT06661356, acronym COMPrEP
StatusNot yet recruiting
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: single, prevention
Enrollment1400 (Estimated)
SponsorUniversity of Alabama at Birmingham (Other); collaborators: National Institute of Mental Health (NIMH), University of Sao Paulo, Federal University of Bahia
ConditionsPre-Exposure Prophylaxis (PrEP), HIV
InterventionsCOMPrEP (Behavioral)
Datesstart 2026-12-01 (estimated), primary completion 2029-08-01 (estimated), completion 2029-08-01 (estimated), first posted 2024-10-28, last updated 2026-10-13
Locations2 sites in Brazil

Related Papers Related Patents Related Grants Related Experts
All trials for Pre-Exposure Prophylaxis (PrEP) All trials for HIV All trials of COMPrEP

-Summary

The goal of this project is to conduct a series of studies to refine, test, and understand experiences with a peer-led community-based intervention in which youth will be integrated into health care teams and trained to deliver HIV pre-exposure prophylaxis (PrEP) to their peers. The study team will conduct a randomized trial to determine if peer delivery of PrEP to youth aged 15-24 in Brazil will increase PrEP uptake, persistence, and adherence compared to standard PrEP care provided in health facilities.

Expand all sections  ·  Collapse all

+Detailed description

HIV is declining in many parts of the world, but rising in Latin America, including Brazil. The HIV epidemic in Brazil, including the number of new infections, is concentrated among youth aged 15-24. Youth in Brazil face obstacles to HIV prevention. Use of HIV pre-exposure prophylaxis (PrEP) lags far behind PrEP need in Brazil. There is international momentum to promote PrEP as prevention and to increase access to low barrier care. Peer lay workers are a promising approach to address the unmet need for PrEP uptake and adherence among youth in Brazil.

COMPrEP is a multi-site randomized controlled trial designed to determine if peer delivery of PrEP to youth aged 15-24 in Brazil will increase PrEP uptake, persistence, and adherence compared to standard PrEP care provided in affirming health facilities. Eligible youth (N=1400) in two municipalities in Brazil (i.e., Salvador and São Paulo) will be randomized to 1:1 to either the COMPrEP intervention arm (PrEP access through peer lay workers in community venues) or the standard care arm (PrEP access through health providers at health facilities). It is anticipated that approximately 245 and 140 youth will initiate PrEP in intervention and standard care arms, respectively, and these will be followed for 12 months, facilitating measurement of PrEP adherence and persistence outcomes on this subset.

+Arms and interventions

ArmTypeInterventionsDescription
Standard Care ArmNo interventionParticipants randomized to the standard care arm will receive PrEP at a health facility from a physician or nurse.
COMPrEP InterventionExperimentalBehavioral: COMPrEPParticipants randomized to the COMPrEP intervention will receive PrEP from peer lay workers at private community locations.
  • COMPrEP (Behavioral): Participants will be paired with peer lay workers and will meet with peer lay workers at private community location. They will discuss options for oral PrEP with peer lay workers and be provided provide daily oral PrEP or event-driven (2-1-1) PrEP. Participants will take part in rapid HIV testing at each visit. They will also meet with peer lay workers at private community location for follow-up at 1, 5, 9, and 13 months.

+Outcome measures

Primary outcomes

  • PrEP Uptake [Within 1 month of enrollment]: Received at least one PrEP prescription

Secondary outcomes

  • PrEP Adherence Biomarker [1 month]: Positive point of care urine tenofovir assay
  • PrEP Adherence Self-Report [At 1, 5, 9, and 13 months]: Number of pills taken in the past 30 days
  • PrEP Persistence [5 months and 13 months]: Continuing to take PrEP at 5 months and 13 months

+Eligibility

Sex: All, ages: 15 Years to 24 Years, accepts healthy volunteers

Eligibility Criteria:

* Aged 15-24 years
* Candidate for HIV prevention
* Sexually active
* Not currently using PrEP
* Willing to discuss oral PrEP
* Agree to be randomized to either intervention or standard care arm

Exclusion Criteria:

* HIV positive test result
* Not currently sexually active
* Currently using PrEP

+Locations (2)

FacilityCityCountryStatus
Federal University of BahiaSalvador, Estado de BahiaBrazil
University of São PauloSão Paulo, São PauloBrazil

+Investigators

+Funding

NIH grants: R01MH135769